Registered medicineMounjaro
- Registered medicine (EMA)
- Studied in clinical trials*
- Doses from 2.5mg to 15mg
- Part of a program with lifestyle coaching and guidance
€269,54/month
Cancel monthly. If you decide not to start after your consultation, you get your money back right away.
Start the questionnaireWeekly injection
2.5mg – 15mg
Tirzepatide
Eli Lilly
How tirzepatide works in your body.
Dual action
Tirzepatide mimics two gut hormones, GIP and GLP-1. That combination curbs your appetite along two routes at once.
Fuller for longer
Your stomach empties more slowly, so you stay full longer after a meal and reach for snacks less often.
Studied in trials
The efficacy and safety of tirzepatide were studied in large clinical trials over 72 weeks.*
Your dose grows with you.
Starting low is not a detour but clinical guideline: your body adjusts and side effects stay manageable. Your doctor sets the pace.
2.5 mg
Weeks 1–4 · adjusting
Your body builds tolerance.
5 mg
From week 5 · maintenance
The steady dose for many clients.
7.5 – 10 mg
Optional
Step by step, when there is reason to.
12.5 – 15 mg
Optional
Only if a higher dose is needed.
Questions along the way? Just message your doctor or coach in the app.
Medication is one part of your program.
- Medical intake and oversight, a doctor assesses your situation and follows your progress
- Online lifestyle program covering nutrition, sleep, stress and exercise
- Personal treatment plan with dosing tailored to you
- Discreet home delivery, cooled and fast
Still deciding between treatments?
During the online consultation the doctor advises what suits you best.
Mounjaro
Wondering whether treatment suits you?
Fill in the questionnaire, it takes about 10 minutes. A doctor reviews your situation and advises whether the treatment suits you.
Start the questionnaireNo obligation · cancel monthly* Refers to published clinical trials of tirzepatide over 72 weeks (SURMOUNT-1). Results vary per person and are no guarantee. Mounjaro is a registered trademark of Eli Lilly and Company. This page is intended to inform, not to promote medicines. Read the package leaflet before use. A doctor always assesses first whether treatment is medically appropriate.
Blog about medical weight loss
Read our articles about medical weight loss, lifestyle, nutrition, medication, obesity, exercise and healthy living.
Wegovy pil goedgekeurd in Europa: de eerste GLP-1 pil voor gewichtsbeheersing
De Europese Commissie heeft de Wegovy pil goedgekeurd als eerste GLP-1 pil voor gewichtsbeheersing in de EU. Wat is er precies goedgekeurd en wanneer komt de pil naar Nederland?
Ontsteking en obesitas: waar start de vicieuze cirkel?
Een diepgaande blik op de complexe relatie tussen obesitas en chronische ontsteking, hoe ze elkaar versterken, en hoe leefstijl en nieuwe behandelingen zoals GLP-1 medicatie deze cirkel kunnen doorbreken.
Wat je moet weten over GLP-1 medicatie (en wat er nog aankomt)
Ontdek de wetenschap achter GLP-1 medicatie: van semaglutide tot revolutionaire combinatiemiddelen die binnenkort op de markt komen en gewichtsverlies transformeren.